Global Rosuvastatin Drugs Market Growth 2022-2028
As the global economy mends, the 2021 growth of Rosuvastatin Drugs will have significant change from previous year. According to our latest study, the global Rosuvastatin Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Rosuvastatin Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Rosuvastatin Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rosuvastatin Drugs market, reaching US$ million by the year 2028. As for the Europe Rosuvastatin Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Rosuvastatin Drugs players cover AstraZeneca, Watson, ANGITA, and Sun Pharmaceutical Industries, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rosuvastatin Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
5 mg Tablet
10 mg Tablet
20 mg Tablet
40 mg Tablet
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hyperlipidemia And Mixed Dyslipidemia
Familial Hypercholesterolemia
Hypertriglyceridemia
Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
Atherosclerosis
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AstraZeneca
Watson
ANGITA
Sun Pharmaceutical Industries
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rosuvastatin Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Rosuvastatin Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Rosuvastatin Drugs by Country/Region, 2017, 2022 & 2028
2.2 Rosuvastatin Drugs Segment by Type
2.2.1 5 mg Tablet
2.2.2 10 mg Tablet
2.2.3 20 mg Tablet
2.2.4 40 mg Tablet
2.3 Rosuvastatin Drugs Sales by Type
2.3.1 Global Rosuvastatin Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Rosuvastatin Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Rosuvastatin Drugs Sale Price by Type (2017-2022)
2.4 Rosuvastatin Drugs Segment by Application
2.4.1 Hyperlipidemia And Mixed Dyslipidemia
2.4.2 Familial Hypercholesterolemia
2.4.3 Hypertriglyceridemia
2.4.4 Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
2.4.5 Atherosclerosis
2.4.6 Others
2.5 Rosuvastatin Drugs Sales by Application
2.5.1 Global Rosuvastatin Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Rosuvastatin Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Rosuvastatin Drugs Sale Price by Application (2017-2022)
3 Global Rosuvastatin Drugs by Company
3.1 Global Rosuvastatin Drugs Breakdown Data by Company
3.1.1 Global Rosuvastatin Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Rosuvastatin Drugs Sales Market Share by Company (2020-2022)
3.2 Global Rosuvastatin Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Rosuvastatin Drugs Revenue by Company (2020-2022)
3.2.2 Global Rosuvastatin Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Rosuvastatin Drugs Sale Price by Company
3.4 Key Manufacturers Rosuvastatin Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rosuvastatin Drugs Product Location Distribution
3.4.2 Players Rosuvastatin Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rosuvastatin Drugs by Geographic Region
4.1 World Historic Rosuvastatin Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Rosuvastatin Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Rosuvastatin Drugs Annual Revenue by Geographic Region
4.2 World Historic Rosuvastatin Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Rosuvastatin Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Rosuvastatin Drugs Annual Revenue by Country/Region
4.3 Americas Rosuvastatin Drugs Sales Growth
4.4 APAC Rosuvastatin Drugs Sales Growth
4.5 Europe Rosuvastatin Drugs Sales Growth
4.6 Middle East & Africa Rosuvastatin Drugs Sales Growth
5 Americas
5.1 Americas Rosuvastatin Drugs Sales by Country
5.1.1 Americas Rosuvastatin Drugs Sales by Country (2017-2022)
5.1.2 Americas Rosuvastatin Drugs Revenue by Country (2017-2022)
5.2 Americas Rosuvastatin Drugs Sales by Type
5.3 Americas Rosuvastatin Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rosuvastatin Drugs Sales by Region
6.1.1 APAC Rosuvastatin Drugs Sales by Region (2017-2022)
6.1.2 APAC Rosuvastatin Drugs Revenue by Region (2017-2022)
6.2 APAC Rosuvastatin Drugs Sales by Type
6.3 APAC Rosuvastatin Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rosuvastatin Drugs by Country
7.1.1 Europe Rosuvastatin Drugs Sales by Country (2017-2022)
7.1.2 Europe Rosuvastatin Drugs Revenue by Country (2017-2022)
7.2 Europe Rosuvastatin Drugs Sales by Type
7.3 Europe Rosuvastatin Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rosuvastatin Drugs by Country
8.1.1 Middle East & Africa Rosuvastatin Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Rosuvastatin Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Rosuvastatin Drugs Sales by Type
8.3 Middle East & Africa Rosuvastatin Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rosuvastatin Drugs
10.3 Manufacturing Process Analysis of Rosuvastatin Drugs
10.4 Industry Chain Structure of Rosuvastatin Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rosuvastatin Drugs Distributors
11.3 Rosuvastatin Drugs Customer
12 World Forecast Review for Rosuvastatin Drugs by Geographic Region
12.1 Global Rosuvastatin Drugs Market Size Forecast by Region
12.1.1 Global Rosuvastatin Drugs Forecast by Region (2023-2028)
12.1.2 Global Rosuvastatin Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rosuvastatin Drugs Forecast by Type
12.7 Global Rosuvastatin Drugs Forecast by Application
13 Key Players Analysis
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Rosuvastatin Drugs Product Offered
13.1.3 AstraZeneca Rosuvastatin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Watson
13.2.1 Watson Company Information
13.2.2 Watson Rosuvastatin Drugs Product Offered
13.2.3 Watson Rosuvastatin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Watson Main Business Overview
13.2.5 Watson Latest Developments
13.3 ANGITA
13.3.1 ANGITA Company Information
13.3.2 ANGITA Rosuvastatin Drugs Product Offered
13.3.3 ANGITA Rosuvastatin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 ANGITA Main Business Overview
13.3.5 ANGITA Latest Developments
13.4 Sun Pharmaceutical Industries
13.4.1 Sun Pharmaceutical Industries Company Information
13.4.2 Sun Pharmaceutical Industries Rosuvastatin Drugs Product Offered
13.4.3 Sun Pharmaceutical Industries Rosuvastatin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sun Pharmaceutical Industries Main Business Overview
13.4.5 Sun Pharmaceutical Industries Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Rosuvastatin Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Rosuvastatin Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 5 mg Tablet
Table 4. Major Players of 10 mg Tablet
Table 5. Major Players of 20 mg Tablet
Table 6. Major Players of 40 mg Tablet
Table 7. Global Rosuvastatin Drugs Sales by Type (2017-2022) & (K Units)
Table 8. Global Rosuvastatin Drugs Sales Market Share by Type (2017-2022)
Table 9. Global Rosuvastatin Drugs Revenue by Type (2017-2022) & ($ million)
Table 10. Global Rosuvastatin Drugs Revenue Market Share by Type (2017-2022)
Table 11. Global Rosuvastatin Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Rosuvastatin Drugs Sales by Application (2017-2022) & (K Units)
Table 13. Global Rosuvastatin Drugs Sales Market Share by Application (2017-2022)
Table 14. Global Rosuvastatin Drugs Revenue by Application (2017-2022)
Table 15. Global Rosuvastatin Drugs Revenue Market Share by Application (2017-2022)
Table 16. Global Rosuvastatin Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Rosuvastatin Drugs Sales by Company (2020-2022) & (K Units)
Table 18. Global Rosuvastatin Drugs Sales Market Share by Company (2020-2022)
Table 19. Global Rosuvastatin Drugs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Rosuvastatin Drugs Revenue Market Share by Company (2020-2022)
Table 21. Global Rosuvastatin Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Rosuvastatin Drugs Producing Area Distribution and Sales Area
Table 23. Players Rosuvastatin Drugs Products Offered
Table 24. Rosuvastatin Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Rosuvastatin Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Rosuvastatin Drugs Sales Market Share Geographic Region (2017-2022)
Table 29. Global Rosuvastatin Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Rosuvastatin Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Rosuvastatin Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Rosuvastatin Drugs Sales Market Share by Country/Region (2017-2022)
Table 33. Global Rosuvastatin Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Rosuvastatin Drugs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Rosuvastatin Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Americas Rosuvastatin Drugs Sales Market Share by Country (2017-2022)
Table 37. Americas Rosuvastatin Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Rosuvastatin Drugs Revenue Market Share by Country (2017-2022)
Table 39. Americas Rosuvastatin Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Americas Rosuvastatin Drugs Sales Market Share by Type (2017-2022)
Table 41. Americas Rosuvastatin Drugs Sales by Application (2017-2022) & (K Units)
Table 42. Americas Rosuvastatin Drugs Sales Market Share by Application (2017-2022)
Table 43. APAC Rosuvastatin Drugs Sales by Region (2017-2022) & (K Units)
Table 44. APAC Rosuvastatin Drugs Sales Market Share by Region (2017-2022)
Table 45. APAC Rosuvastatin Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Rosuvastatin Drugs Revenue Market Share by Region (2017-2022)
Table 47. APAC Rosuvastatin Drugs Sales by Type (2017-2022) & (K Units)
Table 48. APAC Rosuvastatin Drugs Sales Market Share by Type (2017-2022)
Table 49. APAC Rosuvastatin Drugs Sales by Application (2017-2022) & (K Units)
Table 50. APAC Rosuvastatin Drugs Sales Market Share by Application (2017-2022)
Table 51. Europe Rosuvastatin Drugs Sales by Country (2017-2022) & (K Units)
Table 52. Europe Rosuvastatin Drugs Sales Market Share by Country (2017-2022)
Table 53. Europe Rosuvastatin Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Rosuvastatin Drugs Revenue Market Share by Country (2017-2022)
Table 55. Europe Rosuvastatin Drugs Sales by Type (2017-2022) & (K Units)
Table 56. Europe Rosuvastatin Drugs Sales Market Share by Type (2017-2022)
Table 57. Europe Rosuvastatin Drugs Sales by Application (2017-2022) & (K Units)
Table 58. Europe Rosuvastatin Drugs Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Rosuvastatin Drugs Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Rosuvastatin Drugs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Rosuvastatin Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Rosuvastatin Drugs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Rosuvastatin Drugs Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Rosuvastatin Drugs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Rosuvastatin Drugs Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Rosuvastatin Drugs Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Rosuvastatin Drugs
Table 68. Key Market Challenges & Risks of Rosuvastatin Drugs
Table 69. Key Industry Trends of Rosuvastatin Drugs
Table 70. Rosuvastatin Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Rosuvastatin Drugs Distributors List
Table 73. Rosuvastatin Drugs Customer List
Table 74. Global Rosuvastatin Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Rosuvastatin Drugs Sales Market Forecast by Region
Table 76. Global Rosuvastatin Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Rosuvastatin Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Rosuvastatin Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Rosuvastatin Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Rosuvastatin Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Rosuvastatin Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Rosuvastatin Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Rosuvastatin Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Rosuvastatin Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Rosuvastatin Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Rosuvastatin Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Rosuvastatin Drugs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Rosuvastatin Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Rosuvastatin Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Rosuvastatin Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Rosuvastatin Drugs Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Rosuvastatin Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Rosuvastatin Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 94. AstraZeneca Basic Information, Rosuvastatin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. AstraZeneca Rosuvastatin Drugs Product Offered
Table 96. AstraZeneca Rosuvastatin Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. AstraZeneca Main Business
Table 98. AstraZeneca Latest Developments
Table 99. Watson Basic Information, Rosuvastatin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Watson Rosuvastatin Drugs Product Offered
Table 101. Watson Rosuvastatin Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Watson Main Business
Table 103. Watson Latest Developments
Table 104. ANGITA Basic Information, Rosuvastatin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. ANGITA Rosuvastatin Drugs Product Offered
Table 106. ANGITA Rosuvastatin Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. ANGITA Main Business
Table 108. ANGITA Latest Developments
Table 109. Sun Pharmaceutical Industries Basic Information, Rosuvastatin Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Sun Pharmaceutical Industries Rosuvastatin Drugs Product Offered
Table 111. Sun Pharmaceutical Industries Rosuvastatin Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Sun Pharmaceutical Industries Main Business
Table 113. Sun Pharmaceutical Industries Latest Developments
List of Figures
Figure 1. Picture of Rosuvastatin Drugs
Figure 2. Rosuvastatin Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rosuvastatin Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Rosuvastatin Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Rosuvastatin Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 5 mg Tablet
Figure 10. Product Picture of 10 mg Tablet
Figure 11. Product Picture of 20 mg Tablet
Figure 12. Product Picture of 40 mg Tablet
Figure 13. Global Rosuvastatin Drugs Sales Market Share by Type in 2021
Figure 14. Global Rosuvastatin Drugs Revenue Market Share by Type (2017-2022)
Figure 15. Rosuvastatin Drugs Consumed in Hyperlipidemia And Mixed Dyslipidemia
Figure 16. Global Rosuvastatin Drugs Market: Hyperlipidemia And Mixed Dyslipidemia (2017-2022) & (K Units)
Figure 17. Rosuvastatin Drugs Consumed in Familial Hypercholesterolemia
Figure 18. Global Rosuvastatin Drugs Market: Familial Hypercholesterolemia (2017-2022) & (K Units)
Figure 19. Rosuvastatin Drugs Consumed in Hypertriglyceridemia
Figure 20. Global Rosuvastatin Drugs Market: Hypertriglyceridemia (2017-2022) & (K Units)
Figure 21. Rosuvastatin Drugs Consumed in Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
Figure 22. Global Rosuvastatin Drugs Market: Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) (2017-2022) & (K Units)
Figure 23. Rosuvastatin Drugs Consumed in Atherosclerosis
Figure 24. Global Rosuvastatin Drugs Market: Atherosclerosis (2017-2022) & (K Units)
Figure 25. Rosuvastatin Drugs Consumed in Others
Figure 26. Global Rosuvastatin Drugs Market: Others (2017-2022) & (K Units)
Figure 27. Global Rosuvastatin Drugs Sales Market Share by Application (2017-2022)
Figure 28. Global Rosuvastatin Drugs Revenue Market Share by Application in 2021
Figure 29. Rosuvastatin Drugs Revenue Market by Company in 2021 ($ Million)
Figure 30. Global Rosuvastatin Drugs Revenue Market Share by Company in 2021
Figure 31. Global Rosuvastatin Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 32. Global Rosuvastatin Drugs Revenue Market Share by Geographic Region in 2021
Figure 33. Global Rosuvastatin Drugs Sales Market Share by Region (2017-2022)
Figure 34. Global Rosuvastatin Drugs Revenue Market Share by Country/Region in 2021
Figure 35. Americas Rosuvastatin Drugs Sales 2017-2022 (K Units)
Figure 36. Americas Rosuvastatin Drugs Revenue 2017-2022 ($ Millions)
Figure 37. APAC Rosuvastatin Drugs Sales 2017-2022 (K Units)
Figure 38. APAC Rosuvastatin Drugs Revenue 2017-2022 ($ Millions)
Figure 39. Europe Rosuvastatin Drugs Sales 2017-2022 (K Units)
Figure 40. Europe Rosuvastatin Drugs Revenue 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Rosuvastatin Drugs Sales 2017-2022 (K Units)
Figure 42. Middle East & Africa Rosuvastatin Drugs Revenue 2017-2022 ($ Millions)
Figure 43. Americas Rosuvastatin Drugs Sales Market Share by Country in 2021
Figure 44. Americas Rosuvastatin Drugs Revenue Market Share by Country in 2021
Figure 45. United States Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Canada Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Mexico Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Brazil Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. APAC Rosuvastatin Drugs Sales Market Share by Region in 2021
Figure 50. APAC Rosuvastatin Drugs Revenue Market Share by Regions in 2021
Figure 51. China Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Japan Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. South Korea Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Southeast Asia Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. India Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Australia Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Europe Rosuvastatin Drugs Sales Market Share by Country in 2021
Figure 58. Europe Rosuvastatin Drugs Revenue Market Share by Country in 2021
Figure 59. Germany Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. France Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. UK Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Italy Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Russia Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Middle East & Africa Rosuvastatin Drugs Sales Market Share by Country in 2021
Figure 65. Middle East & Africa Rosuvastatin Drugs Revenue Market Share by Country in 2021
Figure 66. Egypt Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 67. South Africa Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 68. Israel Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 69. Turkey Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 70. GCC Country Rosuvastatin Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Rosuvastatin Drugs in 2021
Figure 72. Manufacturing Process Analysis of Rosuvastatin Drugs
Figure 73. Industry Chain Structure of Rosuvastatin Drugs
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
